Cancer Genetics Inc (NASDAQ:CGIX)

11.41
Delayed Data
As of Jul 02
 -0.09 / -0.78%
Today’s Change
4.83
Today|||52-Week Range
12.22
+70.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues3.0M4.3M6.6M10.2M
 
 
 
 
 
Cost of Goods Sold2.7M3.6M4.6M7.6M
 
 
 
 
 
Depreciation And Amortization369.7K353.4K326.5K838.6K
 
 
 
 
 
 
Operating ExpensesGross Income-98.0K372.6K1.7M1.7M
 
 
 
 
 
General Expenses8.1M8.0M9.5M20.0M
 
 
 
 
 
Research And Development2.1M2.1M2.2M3.7M
 
 
 
 
 
Total Operating Expenses11.2M11.9M14.5M28.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.2M-7.6M-7.8M-18.3M
 
 
 
 
 
Extraordinary Credit0.007.5M4.6M615.0K
 
 
 
 
Extraordinary Charge-10.4M-1.9M-7.5M0.00
 
 
 
 
Pre-Tax Equity Earnings0.000.00---939.9K
 
 
Interest Expense On Debt1.3M4.7M2.4M472.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.9M-6.7M-13.0M-19.0M
 
 
 
 
 
Income Taxes0.000.00-663.9K-2.4M
 
 
 
Net Income-19.9M-6.7M-12.4M-16.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M4.0M4.7M9.4M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M4.0M4.7M9.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$15.61-$10.55-$3.64-$1.80
 
 
 
 
 
EPS Diluted-$4.95-$3.54-$3.64-$1.80
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account